Insmed: UBS Maintains Buy Rating, Raises PT to $223 from $194

viernes, 31 de octubre de 2025, 12:02 pm ET1 min de lectura
INSM--

Insmed: UBS Maintains Buy Rating, Raises PT to $223 from $194

Insmed: UBS Maintains Buy Rating, Raises PT to $223 from $194

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios